myelofibrosis Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (2)

Phase 2 (2)

Interventional (2)

Suzhou Zelgen Biopharmaceuticals Co.,Ltd (1)
University of Washington (1)

No (2)

No (2)

Adult (18+) (2)

I am/have/had

I am/have/hadmyelofibrosis

I am/have/hadpolycythemia

I am/have/hadessential thrombocythemia

I am/have/hadthrombocytosis

I am/have/hadanemia

I am/have/hadsecondary myelofibrosis

I am/have/hadcancer

I am/have/hadmyeloproliferative disorder

I am/have/hadextramedullary hematopoiesis

I am/have/hadleukemia

I am/have/hadstem cell transplantation

I am/have/hadgilbert's syndrome

I am/have/hadmyeloid leukemia

I am/have/hadhemolysis

I am/have/hadabsolute neutrophil count

I am/have/hadneutrophil count

I am/have/hadplatelet count

I am/have/hadblast crisis

I am/have/hadmyelodysplastic/myeloproliferative neoplasms

I am/have/hadhepatosplenomegaly

added new label for I am/have/had

more

I am looking for

I am looking forruxolitinib

I am looking forconjugated bilirubin

I am looking fordirect bilirubin

I am looking forhydroxyurea

I am looking forcolony stimulating factor

I am looking forfedratinib

I am looking fordecitabine

I am looking forthiamine

I am looking foriron

I am looking forcytarabine

added new label for I am looking for

more

Advanced Filters

Loading...

Found 2 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 2
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Hematology
Recruiting

Jaktinib Hydrochloride for the Treatment of Ruxolitinib Intolerance of Myelofibrosis

This phase IIB, open-label, multicenter study evaluated the efficacy and safety of oral Jaktinib Dihydrochloride in Intermediate-risk and High-risk Myelofibrosis and Previously Treated With Ruxolitinib

myelofibrosis

absolute neutrophil count

extramedullary hematopoiesis

neutrophil count

red blood cell transfusion

0 views
19 Feb, 2024

Phase 2
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Hematology
Recruiting

Decitabine With Ruxolitinib or Fedratinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms

This phase II trial studies how well decitabine with ruxolitinib or fedratinib works before hematopoietic stem cell transplant in treating patients with accelerated/blast phase myeloproliferative neoplasms (tumors). Drugs used in chemotherapy, such as decitabine, work in different ways to stop the growth of tumor cells, either by killing the cells, …

myelodysplastic/myeloproliferative neoplasms

myelofibrosis

secondary myelofibrosis

fedratinib

blood count

0 views
19 Feb, 2024

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2024 All rights reserved.